TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Study objective
Endpoint domain: General outcomes
Primary endpoint: Heart-rate variability (HRV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initiation of Hepatitis C Virus treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total intraoperative fentanyl dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lumbar paravertebral muscle frequency (tone)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Lumbar paravertebral muscle stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of target ulcers achieving complete wound closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Function in daily living (ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Overall safety and reactogenicity
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline PSQI
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in Inclinometer reading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in Shoulder Pain and Disability Index (SPADI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Dose-adjusted proportion of days covered (PDC) for oral anti-cancer agent
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PDC for chronic condition medications
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Bleeding Rate (all bleeds)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time in Therapeutic Range (TTR) for INR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: IGA treatment success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of CGTC-102
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of CGTC-102
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Change Scores on the Stress Processing Questionnaire (SVF-ak)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total Change Scores on the Perceived Stress Scale (PSS-10)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Numeric Pain Rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24h renal glucose excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Bone mineral density Z-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertebral fracture analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASCQ-Me pain scores
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Attrition to the Telehealth CBT group for older adults
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Neuropathic pain characters and severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: clearance rates of pancreatic duct stones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: MSSA/MRSA colonization in the nares
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: MSSA/MRSA colonization as tested by PCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of adverse events (AEs) and serious adverse events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with laboratory abnormalities that have clinical significance
Endpoint domain: Adverse events/effects
Primary endpoint: Change in minute ventilation (MV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper Limb volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum level of Antimullerian Hormone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Response rate according to metabolic status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in diaphragmatic amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Numbers and incidence of TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Change in heat pain threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Integration of Xauron system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Parental Pro-sipping Beliefs Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients at or above 50% target dose of GDMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelial glycocalyx thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in child development scores on the Malawi Developmental Assessment Tool (MDAT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Responsive care and learning opportunities in the home environment: Home Observation for the Measurement of the Environment (HOME) Inventory score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Composite index of nausea, vomiting, tiredness/fatigue, vertigo, circulation problems/syncopes, muscle cramps, headache, extrasystoles, palpitations, edemas, shortness of breath, depressive mood, anxiety, mental confusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: readiness for discharge
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Hematology Test Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Difference in LF/HF ratio of HRV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: % of lean body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sleep quality and disturbances
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Total number of biopsies with presence of prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of biopsies with clinically significant prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of device and/or procedure related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in bleeding volume as measured by PBAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of Participants with a Major or Probable Major Depressive Episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Participants Reporting Investments in the future
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Proportion of Participants with Unmet Mental Health Service Needs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Unmet Sexual and Reproductive Health Service Needs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change of bone density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Remodeling around the head of dynamic screw
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in total score from PAGI SYM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Dual Task Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of in-hospital major adverse cardiac events (MACE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of Symptoms pointing at Long-Covid after rehabilitation treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of deficits in managing everyday life and work after covid infection
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Clinician Administered PTSD scale for DSM5 (CAPS-5)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PTSD Checklist for DSM5 (PCL5)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Major Adverse Cardiac or Neurological Event
Endpoint domain: Adverse events/effects
Primary endpoint: Visual analogue scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Menstrual Distress Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Low Density Lipoprotein (LDL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Primary Safety Evaluation
Endpoint domain: Adverse events/effects
Primary endpoint: BCG unresponsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Intraoperative Fentanyl consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Quality of breast MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sinus CT scan Lund Mackay score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diaphragma thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to First Occurrence of Composite Events
Endpoint domain: Mortality/survival
Primary endpoint: Acceptability of remote service delivery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Gender Based Violence (GBV) incidence
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Improved self-reported medication adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of patients reclassified for lymph node fixation and/or extrahepatic extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Symbol Digit Modalities Test (SDMT) score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of injury frequency
Endpoint domain: Adverse events/effects
Primary endpoint: STEM/health career attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: STEM/health career self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cerebral infarct volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Speech formant frequencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reach direction for arm movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude of long-latency auditory evoked potentials (from EEG recordings) responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Lowest oxygen saturation level during ETI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Muscle growth rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean Number of Dropouts
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Applied Mental Health Research Dissemination and Implementation Adoption Scale scores (Adoption)
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Applied Mental Health Research Dissemination and Implementation Adoption Scale scores (Implementation)
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: MDS-Unified Parkinson's Disease Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viral Load in Aerosols
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: granulation tissue coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: the time of complete wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of large-for-gestational-age neonates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Correlation of glycated hemoglobin and glycemic variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: successful conception
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: App adherence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Changes in Vh:Cd ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Physical component summary (PCS) scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in parental mental health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in plasma levels of DHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in plasma levels of acylethanolamides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of local recurrences
Endpoint domain: Mortality/survival
Primary endpoint: 3 year survival
Endpoint domain: Mortality/survival
Primary endpoint: Dementia Rating Scale-2 (DRS-2)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Brain-Derived Neurotrophic Factor (BDNF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration (Cmax) of dabigatran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioelectrical impedance analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: abnormal laboratory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful identification rate of group assignment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Forearm's Assisted Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Wrist's Assisted Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of Drug abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of Employment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in California Verbal Learning Test-3 Performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Participants With Different Initial Treatments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of SOT Participants With Unsolicited Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of SOT Participants With Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric Mean Concentration (GMC) of Serum SARS-CoV-2-Specific Neutralizing Antibody (nAb) After the Second Dose in Unvaccinated Participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of neurological deterioration during hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of stroke up to 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Patellofemoral Syndrome Pain Severity Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kujala Patellofemoral Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee Test for Daily Living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: memory recall performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Death or complications
Endpoint domain: Mortality/survival
Primary endpoint: Device closure, defined as residual jet around the device ≤ 3mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ischemic stroke or systemic embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Accuracy of PYLARIFY PET-CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Airflow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of procedure related cardiac Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Hunger area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Satiety area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prospective food consumption area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Symptoms of insomnia
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Electromechanical activation maps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rating of subjective craving
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rating of subjective stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Heart rate response to stress and cannabis cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cortisol response to stress and cannabis cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Knee Injury and Osteoarthritis Outcome Score (Quality of Life)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of participants with treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement of left ventricle ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decreasing of left ventricle end-diastolic diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decreasing of left ventricle end-systolic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Smelling ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of the prototype device Pancreas4ALL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of the prototype device Pancreas4ALL
Endpoint domain: Adverse events/effects
Primary endpoint: PaO2/FiO2 ratio on Day 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of patients diagnosed with pharyngolaryngeal reflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percent of Participants Completing Intervention Period
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Average Acceptability of the EMI-II Intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of Self-reported Cigarette Smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk postural control on wobble chair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Strength and Balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in PANSS-negative symptoms scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking Efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of nursing decisions
Endpoint domain: Adverse events/effects
Primary endpoint: Distance between palpation-based and USG-based determination of the cricothyroid membrane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Neutralizing antibody expressed as geometric mean titer ratio (GMTR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neutralizing antibody expressed as seroresponse rates (SRRs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of patients with Congestive Heart Failure/Pulmonary Edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with hemorrhagic or ischemic Stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients with Acute Kidney Injury (creatinine > 1.5mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of patients with Myocardial Ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients undergoing a thromboembolic event
Endpoint domain: Adverse events/effects
Primary endpoint: Digital mesioidistal crown width of permanent anterior and posterior teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Visual Analogue Scale (VAS) of painfulness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes